Zhejiang Fangge Pharmaceutical Industry

Zhejiang Fangge Pharmaceutical Industry is a leading Chinese biopharmaceutical company specializing in the research and production of medicinal fungal products. Headquartered in Qingyuan, Zhejiang, the company leverages the region's rich fungal resources to develop high-purity polysaccharides and extracts from species such as Ganoderma lucidum and Grifola frondosa. Their operations include large-scale deep fermentation and GMP-certified manufacturing facilities for capsules, powders, and oral liquids. Fangge's products are primarily utilized as adjuvant therapies in oncology and for the treatment of chronic hepatitis and immune system disorders. The company is recognized as a national high-tech enterprise and maintains significant collaborations with academic institutions to advance fungal pharmacology.